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Asbestos Fibers, Plasma and
Inflammation
by John A. Hamilton*t
Fibrin clots have been detected at sites of inflammation, and kinins have been implicated as medi-
ators ofthe vascular phenomena of acute inflammation, systemic shock, and disseminated intravascu-
lar coagulation. It is now reported that both negatively and positively charged asbestos fibers shorten
the partial thromboplastin time of human plasma, indicating coagulation of the plasma. A sample
containing short (<5 Mm in length) chrysotile fibers is ineffective. Only the negatively charged amphi-
boles (crocidolite and amosite) are able to activate factor XII (Hageman factor). This particular effect
ofthe amphiboles is enhanced by high molecular weight kininogen and leads to kinin formation.
Introduction
The critical features of asbestos fibers and the
host responses to these structures, which are both
responsible for the development ofthe inflammation
associated with asbestosis, remain to be elucidated.
Many negatively charged surfaces can cause plasma
to clot, with activation of factor XII being an early
step in the activation of the so-called intrinsic coagu-
lation cascade (1). Fibrin clots have been detected at
sites ofinflammation (2), while several putative medi-
ators of inflammation, for example, kinins and the
products of the fibrinolytic pathway, can also result
from the activation offactor XII (1). Since asbestos fi-
bers have charged surfaces, the interaction of these
fibers with human plasma was examined.
Materials and Methods
Samples
The asbestos and quartz samples were kindly
provided by Dr. A. N. Rohl, Environmental Sciences
Laboratory, Mt. Sinai School of Medicine.
Partial Thromboplastin Time(PTT)
PTT determinations were performed by standard
techniques as described by Ratnoff and Davie (3). Fi-
bers were suspended at 10 mg/mL in 0.1 MTris-HCl,
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0.1 M NaCl, pH 8.0, by sonication for 2 min. Test
samples of 0.1 mL of fiber suspension or 0.1 mL of
buffer control were incubated with 0.1 mL of 0.1%
crude soybean phospholipid (Centrolex-P, Chem-
urgy Div., Central Soy, Chicago. IL). Kaolin (Ameri-
can Standard, acid-washed, Fisher Scientific Co.,
Toronto, Ontario) and quartz, at 10 mg/mL in Cen-
trolex-P, were used as control materials, as they are
known to activate factor XII and thus the intrinsic
clotting pathway (3). After this preincubation for 2
min at 370C, 0.1 mL plasma substrate (ACD, acid-ci-
trate-dextrose, normal human plasma from the Ca-
nadian Red Cross) was added by plastic pipet and
the incubation continued at 370C for an additional 8
min. Finally, 0.1 mL of 0.025 M calcium chloride was
added as cofactor for the enzyme cascade system
and formation of a solid clot was measured after the
time of addition of the calcium chloride. All tests
were carried out in duplicate. The clotting times are
reproducible within 5-10%.
FactorXIIActivation
Activation of factor XII was measured indirectly
by the conversion of prekallikrein to kallikrein as
described previously (4). Stock solutions of fiber
samples (10 mg/mL) were prepared as described
above. Activation of factor XII was measured indi-
rectly as outlined previously (4). Activated factor
XII converts prekallikrein to the protease
kallikrein. The kallikrein was measured spec-
trophotometrically as arginine esterase activity us-
ing the synthetic ester benzoyl-L-arginine ethyl
ester (BAEe) as substrate. Factor XII, HMWJ. A. HAMILTON
kininogen, and prekallikrein/kallikrein were purified
as previously described (4, 5). A 0.1 mL portion of
factor XII (1 mg) was incubated at 37°C with 0.1 mL
fiber suspension or kaolin (10 mg/mL) for 2 min.
Each reaction mixture was further incubated with
0.1 mL HMW kininogen (0.375 mg) or 0.1 mL buffer
for 10 min. Each precipitate was washed and spun
at 40C (3050g for 10 min) and incubated with 0.1 mL
prekallikrein (8.5 mg) for an additional 10 min. A 0.5
mL portion of each supernatant was added to 0.5
mL of 3 mM BAEe (Cyclo Chemical Corp., New
York, NY) and made up to 3 mL with 0.1 M Tris-
HCl, pH 8.0, containing 0.1 M NaCl. The absorbance
due to released benzoyl arginine (BA) was read at 2-
min intervals at 253 nM for 10 min (4). A mixture of
2.5 mL of Tris buffer and 0.5 mL (BAEe served as
the blank. The increase in absorbance is expressed
as nanomoles BAEe hydrolyzed per minute per mil-
liliter of sample, with a standard curve of known
amounts of BA.
Bioassay for Kinin-Forming Activity
Kinin generation after contact activation of factor
XII was assayed by the ability to cause smooth mus-
cle contraction ofthe rat uterus (5). A 0.1 mL portion
of a IARC crocidolite suspension (10 mg/mL) was in-
cubated with 0.1 mL normal human plasma (NHP),
factor XII-deficient plasma (Hird), and HMW kinino-
gen-deficient plasma (Williams) for varying lengths
of time. The mixtures were then boiled for 5 min,
quickly cooled, centrifuged at 40C for 10 min at
3050g, and assayed for kinin activity by the ability to
cause smooth muscle contraction of the estrous rat
uterus (5). For this purpose, virgin albino female rats
(150-180 g) were injected twice with 0.2 mg/kg ofstil-
bestrol (F.W. Horner, Ltd., Montreal, Canada) 48 and
24 hr prior to the assay. The animals were sacrificed
and the horns of the uterus removed. One of the
horns was opened lengthwise and suspended in a 5.0-
mL tissue bath containing oxygenated de Jalon solu-
tion, pH 7.4, at 290C, with 1.0 ,ug/mL atropine sulfate
(Sigma Chemical Co., St. Louis, MO). The uterus was
standardized with synthetic bradykinin (Sandoz,
Montreal, Canada) prepared in concentrations 0.2 to
0.6 ng/mL. Standards were applied to the uterus
every 5 to 6 min and the height of contractions
produced by the standards were recorded on a
kymograph (Palmer, London, England) by a lever
attached to the uterus. A standard curve was pre-
pared by plotting the height of the contractions
against the logarithm of the concentration of the
bradykinin (BK) standards. The experimental sam-
ples were diluted to give concentrations lying within
the dose-response range and the height of the con-
tractions was compared with the known standards.
The total concentration of kinin (ng/mL) present was
calculated by multiplying the dilution factor by the
equivalent response obtained (5). The range of
variation from the duplicate samples was < 5%.
Results
Effect on Partial Thromboplastin Time
Blood remains fluid within the body but quickly
clots when placed in contact with a negatively
charged surface, such as glass, quartz or kaolin (6).
The series of reactions, leading to the clotting of
blood, was called the cascade of coagulation by Mac-
Farlane (7) and can be described as in Figure 1. Con-
tact of the blood with certain surfaces activates fac-
tor XII (Hageman factor) which activates factor XI,
which in turn activates factor IX. Activated factor
IX, in conjunction with phospholipid, calcium and fac-
tor VIII, activates factor X. Activated factor X, in as-
sociation with phospholipid, calcium, and factor V,
causes the rapid conversion of prothrombin to
thrombin. Platelets are the main source of the phos-
pholipid towhichthese clottingfactors can bind.
We have shown (8) that both the negatively
charged amphiboles (IARC crocidolite and IARC
amosite) and the positively charged chrysotiles
INTRINSIC PATHWAY OF BLOOD COAGULATION
Activating
Surface I Factor XII - Factor XlIa
Factor XI / factor XIa
Factor IX Fctor IXa
Factor VM,Cae" Phospho(ipid
Factor X - Factor Xa
Factor V,Ce,
Phosphdipid
Prothrombin - Thrombin
Factor Xm , Factor XMa
Fibrinogen Fibrin gel - Cross-linkedfibrin
FIGURE 1. Intrinsic pathway of blood coagulation. The desig-
nation "a" following the Roman numeral for aclottingfactor
indicates the active form.
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(IARC chrysotile A and IARC chrysotile B) shorten
the PTT of human plasma, indicating acceleration of
coagulation and, at the concentration used (10 mg/-
mL), were comparable to the control samples, kaolin
and quartz (Table 1).
Activation ofFactorXII
The activation of factor XII by contact activation
is in fact more complicated than shown in Figure 1
and, in addition, the kinin-forming and the fibrinoly-
tic pathways are triggered. A milestone in the devel-
opment ofour present concepts was the discovery of
Fletcher trait plasma, deficient in plasma kallikrein,
and Fitzgerald trait plasma, deficient in high molecu-
lar weights (HMW) kininogen. A proposed mechan-
ism for factor XII activation is illustrated in Figure 2
(1, 11). The activation of bound factor XII to an acti-
vating surface is greatly enhanced by HMW-kinino-
gen which is also capable of binding to the surface.
Since HMW-kininogen circulates in plasma with
prekallikrein and factor XI, this interaction helps to
localize factor XII substrates. The generated factor
XIa (Fig. 1) and plasmin participate in intrinsic coag-
ulation and in fibrinolysis, respectively. Kallikrein,
on the other hand, cleaves kininogens to generate
kinins and also clips factor XII which further acti-
vates prekallikrein to kallikrein.
The results in Figure 3 indicate that only the nega-
tively charged fibers, amosite and crocidolite, are
capable of activating factor XII, in the presence of
HMW-kininogen, to generate kallikrein. This behav-
ior is similar to that of the negatively charged stan-
dards, kaolin and quartz.
From Figure 4 it can be seen that crocidolite gene-
rates kinin from normal plasma but not from factor
XII-deficient plasma (Hird) and HMW-kininogen-defi-
cient plasma (Williams). The maximum kinin genera-
Table 1. Effect of asbestos fibers on the partial thromboplastin
(PPT) time of normal human plasma.a
Test substance Clotting time, sec
IARC crocidoliteb 60
IARC amosite 61
IARC chrysotile A 69
IARC chrysotile B 104
Calidria chrysotilec 357
Quartz 67
Kaolin 57
Buffer 234
a Data from Hamilton et al. (8).
b The physicochemical characteristics of the IARC-stan-
dardized asbestos fibers have been reported (9).
c Calidria chrysotile pellets were ultrasonicated for 2 min to
disaggregate the chrysotile to the smallest fibers. The physio-
chemical properties of this material have been described (10).
Approximately 95% of the fibers were calculated to be less
than 5 Am in length(10).
tion was obtained after 5 min incubation using nor-
mal human plasma. These results are typically ob-
tained with the commonly used standard kaolin(4).
Discussion
Contact between asbestos fibers and plasma com-
ponents could possibly result, for example, after fi-
ber-mediated damage ofbronchial or alveolar epithe-
lial surfaces (12); alternatively, fibers might be re-
leased from damaged alveolar macrophages (13)after
transportintoperibronchialareasandlymphatic cap-
illaries. It is proposed that the above findings might
berelevant totheinflammatory processes associated
with asbestosis for the followingreasons. The deposi-
tion offibrin is likely to contribute, in general, to the
induration characteristic of inflammatory responses,
such as delayed type hypersensitivity reactions (14);
in addition, cells such as macrophages, which have
receptors for fibrin(15), might be trapped at a site by
a fibrin deposit. Kinins have been shown to have cer-
tain activities relevant to inflammation, for example,
dilation of blood vessels, increase in vascular perme-
ability and pain induction (1). In this context, Suzuki
and Churg (12) have described the exudation of
edema fluid in alveolar spaces soon after intratra-
cheal injection of chrysotile fibers into hamsters (in-
dicating an increase in vascular permeability), vascu-
lar modifications includingvenous dilation have been
elicited in the hamster cheek pouch by asbestos fi-
bers (16) and the hyperemiainduced in rabbit skin by
asbestos fibers has been quantitated (17). In addition
SURFACE-MEDIATED KININ GENERATION
Factor XI
Prekalikreii
Kininogen
Activating I
-
SurfacelI I
-1 F Factor XlIa_ Z I
" I
±HM W-Kininogen I
n - *Kaikrein -i--_
- .in Kinin
FIGURE 2. Proposed mechanism for the effect of activation of
factor XII on the activation ofprekallikrein. The product of
prekallikrein activation, namely kallikrein, can, in turn,
augment the activation of factor XII while HMW kininogen
promotes the activation of factor XII by surfaces [---,
denotes the effect of factor XIIa on blood coagulation (Fig.
1) and on the activation of plasminogen to plasmin leading
tofibrinolysis].
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FIGURE 3. Activation of factor XII by negatively charged asbestos fibers. The range of
variation from duplicate samples was <5%. Sample numbers were as follows: (1) IARC
chrysotile B; (2) IARC chrysotile A; (3) Calidria chrysotile; (4) IARC amosite; (5) IARC
crocidolite; (6) quartz; (7) kaolin.
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FIGURE4. Generation ofkinin by crocidolite (8).
to fibrin deposition and kinin liberation, the activa-
tion of factor XII can lead to the activation of the
complement system, plasmin formation and the gen-
eration ofbioactive fragments from fibrinogen and fi-
brin (1). Vascular changes have been suggested as
possibly beingrelevant tothe cocarcinogenic proper-
ties(tumor promotion)ofasbestos fibers(17).
The ability ofthe positively charged chrysotiles to
shorten the PTT was surprising, given that nega-
tively charged surfaces are generally required for ac-
tivation of the intrinsic coagulation pathway via fac-
tor XII activation (18). Perhaps another coagulation
sequence is activated. Also, it would be ofinterest to
know whether chrysotiles (in addition toamphiboles)
can generate kinins, even though the samples stud-
ied here did not activate factor XII. The sample of
Calidria chrysotile (with 95% fibers <5pm in length)
had minimal PTT activity; further studies could de-
termine what fiber dimensions are critical in the in-
teraction with plasma. It is important that the prop-
erties of short asbestos fibers be studied since they
are used extensively but are not currently included
in safetystandardsdue tothedifficulty ofdetection.
A cigarette smoke glycoprotein has been shown to
activate factor XII to generate clotting and kinin ac-
tivities (19). It was proposed in this article that the
end result would be vascular effects similar to those
described aboveand therefore mightbeimportant in
the pathogenesis of pulmonary disease associated
with cigarette smoking. It is possible that the find-
ings reported above and those of Becker and Dubin
are relevant to the well-established synergism be-
tween cigarette smoking and asbestos inhalation in
theincidence ofasbestosis(20).
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